Pre-referral artesunate in severe malaria - Authors' reply
| dc.contributor.author | Gomes, M. | |
| dc.contributor.author | Makubalo, L. | |
| dc.contributor.author | Gyapong, J. | |
| dc.contributor.author | Faiz, A. | |
| dc.contributor.author | Warsame, M. | |
| dc.date.accessioned | 2013-08-16T16:04:33Z | |
| dc.date.accessioned | 2017-10-16T12:23:41Z | |
| dc.date.available | 2013-08-16T16:04:33Z | |
| dc.date.available | 2017-10-16T12:23:41Z | |
| dc.date.issued | 2009 | |
| dc.identifier.citation | Gomes, M., Makubalo, L., Gyapong, J., Faiz, A., & Warsame, M. (2009). Pre-referral artesunate in severe malaria - authors' reply. The Lancet, 373(9677), 1763. | en_US |
| dc.identifier.issn | 01406736 | |
| dc.identifier.uri | http://197.255.68.203/handle/123456789/4316 | |
| dc.language.iso | en | en_US |
| dc.subject | EMTREE drug terms: artesunate; placebo | en_US |
| dc.subject | EMTREE medical terms: blood examination; brain damage; death; diagnostic test; disease course; human; letter; malaria; priority journal; rural area | en_US |
| dc.title | Pre-referral artesunate in severe malaria - Authors' reply | en_US |
| dc.type | Article | en_US |